Low-rigidity liposomal formulation
US6613352B2 · kind B2 · utility
40Cited by
65References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 1999 |
| Grant date | Sep 2, 2003 |
| Priority date | — |
| Expiry date | Apr 14, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/127
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a liposomal formulation that is capable of fusing with cells. The liposomal formulation may contain an agent for delivery to cells. The invention also provides compositions and methods for making the liposomal formulation and for liposomal drug delivery. These include methods of killing microbes and of treatment and prevention of microbial infections through the administration of such a formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.